Literature DB >> 25952531

Comparative Analysis of Left- Versus Right-sided Resection in Klatskin Tumor Surgery: can Lesion Side be Considered a Prognostic Factor?

Francesca Ratti1, Federica Cipriani, Guglielmo Piozzi, Marco Catena, Michele Paganelli, Luca Aldrighetti.   

Abstract

BACKGROUND: Achievement of negative margins is the goal of curative intent surgery for hilar cholangiocarcinoma. This study analyzed factors affecting survival in hilar cholangiocarcinoma patients and compared short- and long-term outcomes of left- and right-sided resections.
METHODS: One hundred and five patients out of 124 diagnosed with Klatskin tumors underwent major liver resection. Sixty-one patients underwent right-sided resections (right group), whereas 44 underwent left-sided resections (left group). Perioperative morbidity, perioperative mortality, and overall and disease-free survival were compared between the groups.
RESULTS: Morbidity and mortality were higher in the right group (59 and 8.2%, respectively) than in the left group (38.6 and 2.3%, respectively) (p < 0.005). The most frequent cause of death was liver failure. The R0 rate was 75.4% in the right and 61.4% in the left group. The 5-year survival rate was 42.8% in the right and 35.3% in the left group (p < 0.05). Patients in the left group more frequently developed local recurrence (87 vs. 69% in the right group).
CONCLUSION: Lesion side impacts outcome: right resections still cause significant morbidity related to extensive parenchymal sacrifice but are associated with better long-term survival because right hepatic pedicle resection enables better radicality compared with left resections.

Entities:  

Mesh:

Year:  2015        PMID: 25952531     DOI: 10.1007/s11605-015-2840-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  33 in total

1.  Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma.

Authors:  Michael F Gerhards; Thomas M van Gulik; Dioniso González González; Erik A J Rauws; Dirk J Gouma
Journal:  World J Surg       Date:  2003-02       Impact factor: 3.352

Review 2.  Liver transplantation for cholangiocarcinoma.

Authors:  Charles B Rosen; Julie K Heimbach; Gregory J Gores
Journal:  Transpl Int       Date:  2010-05-20       Impact factor: 3.782

3.  Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma.

Authors:  D Gomez; P B Patel; C Lacasia-Purroy; C Byrne; R P Sturgess; D Palmer; S Fenwick; G J Poston; H Z Malik
Journal:  Eur J Surg Oncol       Date:  2013-10-23       Impact factor: 4.424

4.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz
Journal:  Surgery       Date:  2011-01-14       Impact factor: 3.982

5.  Role of portal vein embolization in liver surgery: single centre experience in sixty-two patients.

Authors:  Francesca Ratti; Corrado Soldati; Marco Catena; Michele Paganelli; Gianfranco Ferla; Luca Aldrighetti
Journal:  Updates Surg       Date:  2010-11-30

6.  Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival.

Authors:  T M van Gulik; J J Kloek; A T Ruys; O R C Busch; G J van Tienhoven; J S Lameris; E A J Rauws; D J Gouma
Journal:  Eur J Surg Oncol       Date:  2010-11-27       Impact factor: 4.424

7.  Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy.

Authors:  Hiroaki Shimizu; Fumio Kimura; Hiroyuki Yoshidome; Masayuki Ohtsuka; Atsushi Kato; Hideyuki Yoshitomi; Katsunori Furukawa; Masaru Miyazaki
Journal:  Ann Surg       Date:  2010-02       Impact factor: 12.969

Review 8.  Hilar cholangiocarcinoma: current management.

Authors:  Fumito Ito; Clifford S Cho; Layton F Rikkers; Sharon M Weber
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

9.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02

10.  Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality.

Authors:  Peter Neuhaus; Sven Jonas; Utz Settmacher; Armin Thelen; Christoph Benckert; Enrique Lopez-Hänninen; Rainer E Hintze
Journal:  Langenbecks Arch Surg       Date:  2003-06-18       Impact factor: 3.445

View more
  11 in total

1.  Unresectable hilar cholangiocarcinoma treated with chemoradiotherapy: a 9-year survival case.

Authors:  Takeshi Sakata; Takahiro Yoshikawa; Takeo Nomi; Yasuko Matsuo; Naoki Kamitani; Daisuke Hokuto; Masayuki Sho
Journal:  Int Cancer Conf J       Date:  2020-09-19

2.  Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar Cholangiocarcinoma.

Authors:  Ryusei Matsuyama; Daisuke Morioka; Ryutaro Mori; Yasuhiro Yabushita; Seigo Hiratani; Yohei Ota; Takafumi Kumamoto; Itaru Endo
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

3.  Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma.

Authors:  Takehiro Noji; Satoko Uemura; Jimme K Wiggers; Kimitaka Tanaka; Yoshitsugu Nakanishi; Toshimichi Asano; Toru Nakamura; Takahiro Tsuchikawa; Keisuke Okamura; Pim B Olthof; William R Jarnagin; Thomas M van Gulik; Satoshi Hirano
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

Review 4.  Systematic review of perioperative and oncologic outcomes of minimally-invasive surgery for hilar cholangiocarcinoma.

Authors:  Federica Cipriani; Francesca Ratti; Guido Fiorentini; Raffaella Reineke; Luca Aldrighetti
Journal:  Updates Surg       Date:  2021-02-22

5.  Liver resection for perihilar cholangiocarcinoma - why left is sometimes right.

Authors:  Sanjay Govil; Anand Bharatan; Ashwin Rammohan; Rathnavel Kanagavelu; Ilankumaran Kaliamoorthy; Mettu S Reddy; Mohamed Rela
Journal:  HPB (Oxford)       Date:  2016-05-26       Impact factor: 3.647

6.  Short- and long-term outcomes after hemihepatectomy for perihilar cholangiocarcinoma: does left or right side matter?

Authors:  Lotte C Franken; Pim B Olthof; Joris I Erdmann; Otto M van Delden; Joanne Verheij; Marc G Besselink; Olivier R Busch; Thomas M van Gulik
Journal:  Hepatobiliary Surg Nutr       Date:  2021-04       Impact factor: 8.265

7.  Comparison analysis of left-side versus right-side resection in bismuth type III hilar cholangiocarcinoma.

Authors:  YouJin Lee; DongWook Choi; Sunjong Han; In Woong Han; Jin Seok Heo; Seong Ho Choi
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-11-27

8.  Left-side vs. right-side hepatectomy for hilar cholangiocarcinoma: a meta-analysis.

Authors:  Wenxuan Wu; Qiyang Cheng; Junru Chen; Diyu Chen; Xiaode Feng; Jian Wu
Journal:  World J Surg Oncol       Date:  2021-04-10       Impact factor: 2.754

9.  Comparison study for surgical outcomes of right versus left side hemihepatectomy to treat hilar cholangiocellular carcinoma.

Authors:  Seung Soo Hong; Dai Hoon Han; Gi Hong Choi; Jin Sub Choi
Journal:  Ann Surg Treat Res       Date:  2019-12-30       Impact factor: 1.859

10.  Right-side versus left-side hepatectomy for the treatment of hilar cholangiocarcinoma: a comparative study.

Authors:  Hye-Sung Jo; Dong-Sik Kim; Young-Dong Yu; Woo-Hyoung Kang; Kyung Chul Yoon
Journal:  World J Surg Oncol       Date:  2020-01-04       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.